中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共12条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Bibliometric and visual analysis in the field of ketogenic diet on cancer from 2012 to 2021 期刊论文
FRONTIERS IN NUTRITION, 2022, 卷号: 9
作者:  Li, Rongrong;  Huang, Qingcheng;  Ye, Chenxiao;  Wu, Changhong;  Luo, Ning;  Lu, Yi;  Fang, Jianqiao;  Wang, Yun
收藏  |  浏览/下载：78/0  |  提交时间：2022/12/23
bibliometric analysis  ketogenic diet  cancer  mechanism  immunotherapy  clinical trials  
Neoadjuvant immunotherapy in non-small-cell lung cancer: a narrative review on mechanisms, efficacy and safety 期刊论文
JOURNAL OF THORACIC DISEASE, 2022
作者:  Shao, Lan;  Lou, Guangyuan
收藏  |  浏览/下载：52/0  |  提交时间：2022/12/22
Neoadjuvant  immunotherapy  immune-checkpoint inhibitors  non-small cell lung cancer (NSCLC)  
Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches 期刊论文
PHARMACEUTICS, 2022, 卷号: 14
作者:  Ji, Qing;  Wu, Yuchen;  Albers, Andreas;  Fang, Meiyu;  Qian, Xu
收藏  |  浏览/下载：47/0  |  提交时间：2022/12/22
oncolytic viruses  nanotechnology  oncolytic virotherapy  immunotherapy  melanoma  head and neck cancer  
If small molecules immunotherapy comes, can the prime be far behind? 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 218
作者:  Zhang, Jingyu;  Zhang, Yu;  Qu, Bingxue;  Yang, Haiyan;  Hu, Shengquan;  Dong, Xiaowu
收藏  |  浏览/下载：61/0  |  提交时间：2021/06/15
Cancer immunotherapy  Small molecule inhibitors  Combination therapy  Tumor microenvironment  
Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China 期刊论文
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021
作者:  Zhang, Xiangyu;  Zeng, Liang;  Li, Yizhi;  Xu, Qinqin;  Yang, Haiyan;  Lizaso, Analyn;  Mao, Xinru;  Jin, Ren'an;  Zeng, Yu;  Li, Qinglin;  Wang, Jianbo;  Li, Yang;  Zhang, Yongchang;  Yang, Nong
收藏  |  浏览/下载：56/0  |  提交时间：2021/03/15
Anlotinib  Immunotherapy  Programmed death 1 inhibitor  Lung cancer  
Case Report: Significant Response to Immune Checkpoint Inhibitor Camrelizumab in a Heavily Pretreated Advanced ER+/HER2-Breast Cancer Patient With High Tumor Mutational Burden 期刊论文
FRONTIERS IN ONCOLOGY, 2021, 卷号: 10
作者:  Wang, Rong;  Yang, Yuchen;  Ye, Wei-Wu;  Xiang, Jianxing;  Chen, Songan;  Zou, Wei-Bin;  Wang, Xiao-Jia;  Chen, Tianhui;  Cao, Wen-Ming
收藏  |  浏览/下载：58/0  |  提交时间：2021/04/26
breast cancer  immunotherapy  biomarker  TMB  NGS  molecular monitoring  
Beyond Blocking: Engineering RNAi-Mediated Targeted Immune Checkpoint Nanoblocker Enables T-Cell-lndependent Cancer Treatment 期刊论文
ACS NANO, 2020, 卷号: 14
作者:  Han, Xiaoyan;  Wang, Linlin;  Li, Ting;  Zhang, Jiahui;  Zhang, Dailiang;  Li, Jili;  Xia, Yinghao;  Liu, Yanlan;  Tan, Weihong
收藏  |  浏览/下载：58/0  |  提交时间：2021/03/15
immune checkpoint blockade  RNAi engineering  nanostructure  NSCLC  cancer immunotherapy  
PD-1 inhibitor combined with apatinib for advanced gastric or esophagogastric junction cancer: a retrospective study 期刊论文
TRANSLATIONAL CANCER RESEARCH, 2020, 卷号: 9
作者:  Wei, Qing;  Yuan, Xing;  Li, Jingjing;  Xu, Qi;  Ying, Jieer
收藏  |  浏览/下载：58/0  |  提交时间：2020/11/30
Programmed death 1 (PD-1)  gastric cancer (GC)  immune checkpoint inhibitors  immunotherapy  apatinib  
Durvalumab monotherapy as a third-line treatment for extensive-stage small-cell lung cancer: a case report 期刊论文
ANNALS OF PALLIATIVE MEDICINE, 2020, 卷号: 9
作者:  Zhou, Qinfei;  Zhao, Jiazheng;  Wang, Jie;  Bao, Guanai;  Gong, Li-Yan
收藏  |  浏览/下载：54/0  |  提交时间：2020/11/26
Small-cell lung cancer (SCLC)  immunotherapy  durvalumab  third-line treatment  case report  
PD-L1 expression and T cells infiltration in patients with uncommon EGFR-mutant non-small cell lung cancer and the response to immunotherapy 期刊论文
LUNG CANCER, 2020, 卷号: 142
作者:  Chen, Kaiyan;  Cheng, Guoping;  Zhang, Fanrong;  Zhu, Guanxia;  Xu, Yanjun;  Yu, Xiaoqing;  Huang, Zhiyu;  Fan, Yun
收藏  |  浏览/下载：62/0  |  提交时间：2020/11/26
Uncommon EGFR  Non-small cell lung cancer  PD-L1  T cell  Immunotherapy